Technology area: Medical Devices & Mechanical Engineering
21 pending office actions • 10 art units • 20 examiners • 0 of 21 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Medtronic Ireland Manufacturing Unlimited Company has 21 pending office actions in Medical Devices & Mechanical Engineering. The portfolio spans 20 distinct examiners and 10 distinct art units, indicating broad examiner coverage with repeated activity within technical groups.
ZINK, AMANDA L is the busiest examiner, with 2 pending matters. That assignment creates a limited focal point for examiner-specific review, while most of the portfolio remains distributed across other examiners.
The examiner count being twice the art-unit count indicates that multiple examiners are active within some medical-device groupings. Counsel should distinguish art-unit patterns from individual examination practices when assessing recurring claim, enablement, or prior-art issues.
Centralized controls can support consistent terminology, disclosure management, and related-application coordination. Individual response strategies remain necessary because the available assignments combine shared technical settings with broad examiner dispersion.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (14%) |
| §103 only | 9 (43%) |
| §102 only | 2 (10%) |
| §112 only | 1 (5%) |
| Double-patenting only | 1 (5%) |
| Multi-statute (no §101) | 3 (14%) |
| No statute on record | 2 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZINK, AMANDA L | 2 | 85.2% | +3.1% |
| BRUTUS, JOEL F | 1 | 72.9% | +17.7% |
| NASSER, ROBERT L | 1 | 73.0% | +11.2% |
| SMITH, KAITLYN ELIZABETH | 1 | 58.1% | +15.0% |
| CERIONI, DANIEL LEE | 1 | 64.3% | +28.0% |
| ALTER MORSCHAUSER, ALYSSA MARGO | 1 | 76.6% | +15.7% |
| NGUYEN, HIEN NGOC | 1 | 52.7% | +40.8% |
| COLLINS, SEAN W | 1 | 74.7% | +26.2% |
| ZIEGLER, ABIGAIL M | 1 | 47.3% | +46.7% |
| MORALES, JON ERIC C | 1 | 85.4% | +10.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18717328 | IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY | MORALES, JON ERIC C | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18649578 | REMOTE PATIENT MONITORING AND CARE COORDINATION PLATFORM TO SUPPORT HYPERTENSION CARE OPTIMIZATION | EDOUARD, JONATHAN CHRISTOPHER | 83d |
| 19471252 | FOCUSED ULTRASOUND STIMULATION FOR RENAL DENERVATION | BRUTUS, JOEL F | — |
| 19109478 | IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY | CERIONI, DANIEL LEE | — |
| 18861090 | BALLOON CATHETER SYSTEM | NGUYEN, HIEN NGOC | — |
| 18582754 | SELECTION OF DENERVATION THERAPY | STEINBERG, AMANDA L | — |
| 18211070 | MEASURING RENAL ARTERY DISTENSIBILITY AND/OR COMPLIANCE FROM MEDICAL IMAGES | JANG, CHRISTIAN Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19471252 | FOCUSED ULTRASOUND STIMULATION FOR RENAL DENERVATION | BRUTUS, JOEL F | — |
| 19129470 | CRYOABLATION CATHETER WITH VARYING CROSS-SECTIONAL SHAPE | NASSER, ROBERT L | — |
| 19195105 | CATHETER APPARATUSES, SYSTEMS, AND METHODS FOR RENAL NEUROMODULATION | SMITH, KAITLYN ELIZABETH | — |
| 19109478 | IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY | CERIONI, DANIEL LEE | — |
| 19029521 | CATHETER APPARATUSES HAVING MULTI-ELECTRODE ARRAYS FOR RENAL NEUROMODULATION AND ASSOCIATED SYSTEMS AND METHODS | ALTER MORSCHAUSER, ALYSSA MARGO | — |
| 18861090 | BALLOON CATHETER SYSTEM | NGUYEN, HIEN NGOC | — |
| 18806111 | SYSTEMS AND METHODS FOR EVALUATING NEUROMODULATION THERAPY VIA HEMODYNAMIC RESPONSES | COLLINS, SEAN W | — |
| 18720963 | NEUROMODULATION CATHETER | ZIEGLER, ABIGAIL M | — |
| Art Unit | Apps |
|---|---|
| 3794 | 9 |
| 3797 | 2 |
| 3796 | 2 |
| 3792 | 2 |
| 3992 | 1 |
| 3791 | 1 |
| 3683 | 1 |
| 3993 | 1 |
| 3771 | 1 |
| 1796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19471252 | FOCUSED ULTRASOUND STIMULATION FOR RENAL DENERVATION | BRUTUS, JOEL F | 3797 | §102§103 | Non-Final OA | — | Pending | Sep 30, 2025 |
| 19129470 | CRYOABLATION CATHETER WITH VARYING CROSS-SECTIONAL SHAPE | NASSER, ROBERT L | 3992 | §103 | Non-Final OA | — | Pending | May 13, 2025 |
| 19195105 | CATHETER APPARATUSES, SYSTEMS, AND METHODS FOR RENAL NEUROMODULATION | SMITH, KAITLYN ELIZABETH | 3794 | DP | Non-Final OA | — | Pending | Apr 30, 2025 |
| 19109478 | IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY | CERIONI, DANIEL LEE | 3791 | §101§112 | Non-Final OA | — | Pending | Mar 06, 2025 |
| 19029521 | CATHETER APPARATUSES HAVING MULTI-ELECTRODE ARRAYS FOR RENAL NEUROMODULATION AND ASSOCIATED SYSTEMS AND METHODS | ALTER MORSCHAUSER, ALYSSA MARGO | 3796 | §112Other | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18861090 | BALLOON CATHETER SYSTEM | NGUYEN, HIEN NGOC | 3797 | §102§103 | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18806111 | SYSTEMS AND METHODS FOR EVALUATING NEUROMODULATION THERAPY VIA HEMODYNAMIC RESPONSES | COLLINS, SEAN W | 3794 | §103 | Final Rejection | — | Pending | Aug 15, 2024 |
| 18720963 | NEUROMODULATION CATHETER | ZIEGLER, ABIGAIL M | 3794 | §103 | Final Rejection | — | Pending | Jun 17, 2024 |
| 18717328 | IDENTIFYING SUITABLE CANDIDATES FOR DENERVATION THERAPY | MORALES, JON ERIC C | 3796 | §103 | Final Rejection | — | Pending | Jun 06, 2024 |
| 18669595 | AMPLITUDE MODULATION TO ASSESS CATHETER ENVIRONMENT | VAHDAT, KHADIJEH A | 3794 | §102 | Non-Final OA | — | Pending | May 21, 2024 |
| 18649578 | REMOTE PATIENT MONITORING AND CARE COORDINATION PLATFORM TO SUPPORT HYPERTENSION CARE OPTIMIZATION | EDOUARD, JONATHAN CHRISTOPHER | 3683 | §101§102§103 | Non-Final OA | 83d | Pending | Apr 29, 2024 |
| 18582754 | SELECTION OF DENERVATION THERAPY | STEINBERG, AMANDA L | 3792 | §101§103 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18577342 | CRYOTHERAPEUTIC TREATMENT DEVICES | STOKLOSA, JOSEPH A | 3794 | §103 | Final Rejection | — | Pending | Jan 08, 2024 |
| 18399810 | NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES | ZINK, AMANDA L | 3794 | Other | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18399817 | NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES | ZINK, AMANDA L | 3794 | Other | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18377585 | INTRACARDIAC TOOLS AND METHODS FOR DELIVERY OF ELECTROPORATION THERAPIES | KADING, JOSHUA A | 3993 | §103 | Non-Final OA | 69d | Pending | Oct 06, 2023 |
| 18339847 | SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR NEUROMODULATION IN HETEROGENEOUS TISSUE ENVIRONMENTS | EKRAMI, YASAMIN | 3794 | §102 | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18211070 | MEASURING RENAL ARTERY DISTENSIBILITY AND/OR COMPLIANCE FROM MEDICAL IMAGES | JANG, CHRISTIAN Y | 3792 | §103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18333274 | INTEGRATED CHECK VALVE FOR HEATING ELEMENT COOLING IN OCCLUSIVE DENERVATION CATHETERS | RABAGLIA, BRIDGET ELIZABETH | 3771 | §103 | Final Rejection | — | Pending | Jun 12, 2023 |
| 17820728 | MIMICKING PHYSIOLOGIC CONDITIONS DURING ORGAN OR TISSUE PERFUSION | MARCHESCHI, MICHAEL A | 1796 | §103 | Non-Final OA | — | Pending | Aug 18, 2022 |
| 17038336 | HELICAL PUSH WIRE ELECTRODE | DELLA, JAYMI E | 3794 | §103 | Non-Final OA | — | Pending | Sep 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMedtronic Ireland Manufacturing Unlimited Company has 21 pending office actions as of October 2026, spread across 10 art units and 20 examiners.
Amanda L Zink has the most, with 2 of Medtronic Ireland Manufacturing Unlimited Company's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
